Suppr超能文献

2012 年至 2017 年期间中国北京健康人群中肠道病毒 D68 的血清流行病学:一项回顾性研究。

Seroepidemiology of enterovirus D68 in a healthy population in Beijing, China, between 2012 and 2017: A retrospective study.

机构信息

College of Public Health, Capital Medical University, Beijing, China.

Planned Immunity Inoculation Institute, Beijing Center for Disease Prevention and Control, Beijing, China.

出版信息

J Med Virol. 2021 Jun;93(6):3524-3531. doi: 10.1002/jmv.26132. Epub 2020 Oct 5.

Abstract

To investigate the seroepidemiological features of enterovirus D68 (EV-D68) in the healthy population from 2012 to 2017 in Beijing, China. A retrospective cross-sectional investigation was conducted using serum specimens collected from healthy individuals in Beijing from 2012 to 2017. These samples were tested for neutralization antibodies (NtAbs) against EV-D68. The sera from six EV-D68 infected patients in the acute or convalescent phase were used to determine the protection level of NtAbs against EV-D68. The geometric means of the titers (GMT) of EV-D68 NtAbs in 2012 and 2017 were 92.82 and 242.91, respectively; the seroprevalences of EV-D68 were 89.43% and 98.43%, respectively. The GMT reached its peak in the 11 to 15 age group in 2012, while in 16 to 20 age group in 2017. We also observed that EV-D68 NtAbs titers of six sera from the acute phase were all less than equal to  1:64 and that of three sera from the convalescent phase were all more than 1:64. Anti-EV-D68 NtAbs in the population remained low from 2012 to 2016 but increased significantly in 2017. Although most of the EV-D68 infections remain undetected in Beijing, the risk of a large outbreak of EV-D68 exists and should be taken seriously.

摘要

为了调查中国北京健康人群中 2012 至 2017 年肠道病毒 D68(EV-D68)的血清流行病学特征,采用回顾性横断面研究方法,使用 2012 至 2017 年北京采集的健康人群血清标本进行检测。这些标本检测针对 EV-D68 的中和抗体(NtAb)。使用 6 份处于急性或恢复期 EV-D68 感染患者的血清,来确定 NtAb 针对 EV-D68 的保护水平。2012 年和 2017 年 EV-D68 NtAb 的几何平均滴度(GMT)分别为 92.82 和 242.91;EV-D68 的血清流行率分别为 89.43%和 98.43%。2012 年 11 至 15 岁年龄组 GMT 达到峰值,而 2017 年则为 16 至 20 岁年龄组。我们还观察到,6 份急性期血清的 EV-D68 NtAb 滴度均小于等于 1:64,而 3 份恢复期血清的滴度均大于 1:64。2012 年至 2016 年,人群中抗 EV-D68 NtAb 水平一直较低,但 2017 年显著增加。尽管在北京大多数 EV-D68 感染仍未被发现,但存在 EV-D68 大规模暴发的风险,应予以重视。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验